SCHEMBL3831411

SCHEMBL3831411

Cc1ccc2cnc(-c3ccccc3C)cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
NPC1 O15118 3/20 0.47
MAP4K1 Q92918 1/20 0.44
CYP1A2 P05177 6/20 0.44
CYP2D6 P10635 4/20 0.44
CYP2C19 P33261 4/20 0.44
ALDH1A1 P00352 3/20 0.44
CYP3A4 P08684 3/20 0.44
ALOX15 P16050 3/20 0.44
HSD17B10 Q99714 2/20 0.44
CLK4 Q9HAZ1 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
CYP2A6 P11509 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
RAB9A P51151 2/20 0.42
IDO1 P14902 1/20 0.41
METAP2 P50579 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3826324 0.93 L3MBTL1 (0.50) CASP3SENP8SENP7SENP6NPC1
SCHEMBL807820 0.86 NPC1 (0.62) CASP3SENP8SENP7SENP6NPC1
SCHEMBL3826128 0.84 CASP3 (0.72) CASP3SENP8SENP7SENP6NPC1
SCHEMBL3825502 0.81 CASP3 (0.49) CASP3SENP8SENP7SENP6NPC1
SCHEMBL3829233 0.81 CYP1A2 (0.43) CASP3SENP8SENP7SENP6MAP4K1
SCHEMBL27761188 0.80 CASP3 (0.44) CASP3SENP8SENP7SENP6NPC1
SCHEMBL19258030 0.78 CASP3 (0.43) CASP3SENP8SENP7SENP6NPC1
SCHEMBL3832328 0.78 L3MBTL1 (0.72) CASP3SENP8SENP7SENP6NPC1
SCHEMBL3826323 0.78 NPC1 (0.50) CASP3SENP8SENP7SENP6NPC1
SCHEMBL14102704 0.76 NPC1 (0.72) CASP3SENP7NPC1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-A2 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS Rexahn Pharmaceuticals, Inc. (US) 2009-09-16 EP disclosed
WO-2008063548-A2 5, 6, OR 7-SUBSTITUTED-S- (HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed